Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image 6 November 2023 Vol. No. 12; Issue No. 603

1. Pelizzola M, Tanderup K, Chopra S, Jürgenliemk-Schulz IM, Nout R, Kirchheiner K, Spampinato S (2023). Co-occurrence of symptoms after radiochemotherapy in locally advanced cervix cancer patients: A cluster analysis. Acta Oncologica

2. Kothekar AT, Mohanty R, Joshi AV (2023). Goal-directed fluid therapy in neurosurgery: Three feet from gold? Indian Journal of Critical Care Medicine. 27(10):697-698.

3. Biswas S, Mandal G, Anadon C, Chaurio R, Lopez-Bailon L, Nagy M, Mine J, Hänggi K, Sprenger K, Innamarato P, Harro C, Powers J, Johnson J, Fang B, Eysha M, Nan X, Li R, Perez B, Curiel T, Yu X, Rodriguez P, Conejo-Garcia J (2023). Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancers. Immunity.

4. Boppana M, Sengar M, Jain H, Gurjar M, Ambotkar M, Gota V, Bonda A, Bagal B, Thorat J, Gokarn A, Nayak L, Shetty N, Baheti A, Mokal S, Kannan S, Shetty A, Eipe T (2023). A prospective study to evaluate the effect of therapeutic drug monitoring-based posaconazole prophylaxis on invasive fungal infection rate during acute myeloid leukemia induction therapy. Indian Journal of Hematology and Blood Transfusion.

5. Leung K, McLeod M, Torode J, Ilbawi A, Chakowa J, Bourbeau B, Sengar M, Booth CM, Gralow JR, Sullivan R, Aggarwal A (2023). Quality indicators for systemic anticancer therapy services: a systematic review of metrics used to compare quality across healthcare facilities. European Journal of Cancer. 195:113389

6. Shabrish S, Chandrakasan S, Madkaikar M (2023). NK cell defects: diagnosis and treatment. Frontiers in Immunology. 14:1323793.

7. Ghosh S, Goda J, Chatterjee A, Shetty P, Sahay A, Dasgupta A, Epari S, Sahu A, Singh V, Gupta T, Moiyadi A, Jalali R (2023). Patterns of care in Craniopharyngioma: Clinical outcomes following surgery and radiation therapy in a real world setting. World Neurosurgery.

Book Chapters
Moiyadi A, Shetty P, Velayutham P, Singh VK, Jain K. (2023). Intraoperative Mapping and Monitoring Techniques for Intra-Axial Brain Tumors. In: Shah A, Goel A, Kato Y. (Eds) Functional Anatomy of the Brain: A View from the Surgeon’s Eye. Springer, Singapore. (ISBN: 978-981-99-3411-9)

Singh B, Dutt S. (2024). Role of Cancer Stem Cells in Maintenance of Tumor Heterogeneity in Brain Tumors. In: Pathak S, Banerjee A (Eds.) Cancer Stem Cells and Signaling Pathways. Academic Press, Pp:165-184. (ISBN: 978-0-443-13212-4).

Site of the Week

The Open Access Series of Imaging Studies (OASIS) is aimed at making neuroimaging data sets of the brain freely available to the scientific community.

desktop Image
Interesting Reads

Bartman CR, Faubert B, Rabinowitz JD, DeBerardinis RJ (2023). Metabolic pathway analysis using stable isotopes in patients with cancer. Nature Reviews Cancer.

Video of the Week
The Latest in Immunotherapy to Treat Cancer
Upcoming Events
18th International Congress of Immunology

27 November-02 December, 2023

At Cape Town, South Africa.

International Conference on Drug Discovery and Translational Medicine 2023

04-08 December, 2023

At Unicorn Hotel, Seri Kembangan, Malaysia.

Cell Bio 2023

04-06 December, 2023

At Boston, MA.

Do You Know?

In 1997, FDA approved Rituxan (rituximab), the first monoclonal antibody, to treat non-Hodgkin’s lymphoma.

back Image
Cancer News
Indian Cancer Congress concludes with impactful deliberations

05 November 2023, Free Press Journal

Dr. Sudeep Gupta, professor of medical oncology at Tata Memorial Centre and the scientific chairperson of ICC, said one of the important achievements of this congress is the presentation of over 2,000 original research abstracts by young doctors and scientists from various parts of India. ICC collaborated with internationally renowned cancer organisations such as the American Society of Clinical Oncology (ASCO), the European Society of Medical Oncology (ESMO), the Society of Surgical Oncologists, and others, in this congress...

New drug shows promise in killing cancer cells with genetic vulnerability

01 November 2023, News Medical

The MRTX1719 drug targets cancers with a genetic vulnerability – the absence of tumor suppressor gene CDKN2A and its neighbor gene, MTAP. These missing genes can lead to uncontrolled cell growth, but the drug exploits this weakness to fight the cancer...

New NK cell engaging immunotherapy approaches to target and potentially treat recalcitrant ovarian cancer

01 November 2023, MedicalXpress

The researchers demonstrated that multiple OC carrying mutations, including BRCA1 and BRCA2, could be targeted by Siglec-7 antibodies through activated NK cells...

2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)